Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

Market Analysis and Insights: Global Standard Lancets Market
In 2020, the global Standard Lancets market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Standard Lancets Scope and Market Size
The global Standard Lancets market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Standard Lancets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Needle
Blade

Segment by Application
Hospitals and Clinics
Homecare Settings
Others

By Company
Roche
Lifescan
BD
Bayer
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Omron
Infopia
AgaMatrix
Smiths Medical
Sarstedt
SANNUO
Yicheng
Yuwell
Greiner Bio One
Edan
Narang Medical

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE